(Q61774247)

English

High-dose sequential chemotherapy and in vivo rituximab-purged stem cell autografting in mantle cell lymphoma: a 10-year update of the R-HDS regimen

scientific article published on 27 October 2008

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18955979%20AND%20SRC:MED&resulttype=core&format=json

25 December 2019

High-dose sequential chemotherapy and in vivo rituximab-purged stem cell autografting in mantle cell lymphoma: a 10-year update of the R-HDS regimen (English)

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18955979%20AND%20SRC:MED&resulttype=core&format=json

25 December 2019

0 references

1 reference

based on heuristic

inferred from title

mantle cell lymphoma

1 reference

based on heuristic

inferred from title

Massimo Di Nicola

2

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18955979%20AND%20SRC:MED&resulttype=core&format=json

25 December 2019

Carmelo Carlo-Stella

3

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18955979%20AND%20SRC:MED&resulttype=core&format=json

25 December 2019

Liliana Devizzi

5

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18955979%20AND%20SRC:MED&resulttype=core&format=json

25 December 2019

author name string

M Magni

1

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18955979%20AND%20SRC:MED&resulttype=core&format=json

25 December 2019

P Matteucci

4

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18955979%20AND%20SRC:MED&resulttype=core&format=json

25 December 2019

C Tarella

6

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18955979%20AND%20SRC:MED&resulttype=core&format=json

25 December 2019

F Benedetti

7

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18955979%20AND%20SRC:MED&resulttype=core&format=json

25 December 2019

M Martelli

8

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18955979%20AND%20SRC:MED&resulttype=core&format=json

25 December 2019

C Patti

9

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18955979%20AND%20SRC:MED&resulttype=core&format=json

25 December 2019

G Parvis

10

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18955979%20AND%20SRC:MED&resulttype=core&format=json

25 December 2019

A Rambaldi

11

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18955979%20AND%20SRC:MED&resulttype=core&format=json

25 December 2019

T Barbui

12

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18955979%20AND%20SRC:MED&resulttype=core&format=json

25 December 2019

A M Gianni

13

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18955979%20AND%20SRC:MED&resulttype=core&format=json

25 December 2019

language of work or name

0 references

publication date

27 October 2008

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18955979%20AND%20SRC:MED&resulttype=core&format=json

25 December 2019

Bone Marrow Transplantation

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18955979%20AND%20SRC:MED&resulttype=core&format=json

25 December 2019

43

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18955979%20AND%20SRC:MED&resulttype=core&format=json

25 December 2019

6

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18955979%20AND%20SRC:MED&resulttype=core&format=json

25 December 2019

509-511

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18955979%20AND%20SRC:MED&resulttype=core&format=json

25 December 2019

https://scigraph.springernature.com/pub.10.1038/bmt.2008.349

0 references

Immunochemotherapy with rituximab and cyclophosphamide, doxorubicin, vincristine, and prednisone significantly improves response and time to treatment failure, but not long-term outcome in patients with previously untreated mantle cell lymphoma: res

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2008.349

7 January 2021

based on heuristic

inferred from DOI database lookup

High-dose chemoradiotherapy and anti-B-cell monoclonal antibody-purged autologous bone marrow transplantation in mantle-cell lymphoma: no evidence for long-term remission

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2008.349

7 January 2021

based on heuristic

inferred from DOI database lookup

Rituximab: enhancing stem cell transplantation in mantle cell lymphoma

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2008.349

7 January 2021

based on heuristic

inferred from DOI database lookup

A new prognostic index (MIPI) for patients with advanced-stage mantle cell lymphoma

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2008.349

7 January 2021

based on heuristic

inferred from DOI database lookup

Rituximab induces effective clearance of minimal residual disease in molecular relapses of mantle cell lymphoma.

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2008.349

7 January 2021

based on heuristic

inferred from DOI database lookup

Update of the M. D. Anderson Cancer Center experience with hyper-CVAD and rituximab for the treatment of mantle cell and Burkitt-type lymphomas.

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2008.349

7 January 2021

based on heuristic

inferred from DOI database lookup

Long-term progression-free survival of mantle cell lymphoma after intensive front-line immunochemotherapy with in vivo-purged stem cell rescue: a nonrandomized phase 2 multicenter study by the Nordic Lymphoma Group

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2008.349

7 January 2021

based on heuristic

inferred from DOI database lookup

Ki-67 predicts outcome in advanced-stage mantle cell lymphoma patients treated with anti-CD20 immunochemotherapy: results from randomized trials of the European MCL Network and the German Low Grade Lymphoma Study Group

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2008.349

7 January 2021

based on heuristic

inferred from DOI database lookup

Multicenter phase II study of bortezomib in patients with relapsed or refractory mantle cell lymphoma

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2008.349

7 January 2021

based on heuristic

inferred from DOI database lookup

Phase II trial of single-agent temsirolimus (CCI-779) for relapsed mantle cell lymphoma

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2008.349

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q61774247&oldid=1953722181"